SAIEX
Price
$11.11
Change
+$0.07 (+0.63%)
Updated
Jan 17 closing price
Net Assets
210.42M
SPMHX
Price
$9.26
Change
+$0.04 (+0.43%)
Updated
Jan 17 closing price
Net Assets
1.11B
Ad is loading...

SAIEX vs SPMHX

Header iconSAIEX vs SPMHX Comparison
Open Charts SAIEX vs SPMHXBanner chart's image
Spirit of America Energy Institutional
Price$11.11
Change+$0.07 (+0.63%)
VolumeN/A
Net Assets210.42M
Invesco SteelPath MLP Alpha R5
Price$9.26
Change+$0.04 (+0.43%)
VolumeN/A
Net Assets1.11B
SAIEX vs SPMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SAIEX vs. SPMHX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAIEX is a StrongBuy and SPMHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SPMHX has more cash in the bank: 1.11B vs. SAIEX (210M). SAIEX pays higher dividends than SPMHX: SAIEX (16.06) vs SPMHX (5.12). SAIEX was incepted earlier than SPMHX: SAIEX (5 years) vs SPMHX (6 years). SPMHX is a more actively managed with annual turnover of: 32.00 vs. SAIEX (15.00). SAIEX has a lower initial minimum investment than SPMHX: SAIEX (100000) vs SPMHX (1000000). SPMHX annual gain was more profitable for investors over the last year : 53.21 vs. SAIEX (34.34).
SAIEXSPMHXSAIEX / SPMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years6 years-
Gain YTD10.0007.258138%
Front LoadN/AN/A-
Min. Initial Investment100000100000010%
Min. Initial Investment IRAN/AN/A-
Net Assets210M1.11B19%
Annual Yield % from dividends16.065.12314%
Returns for 1 year34.3453.2165%
Returns for 3 years77.32114.4568%
Returns for 5 yearsN/A132.42-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FINV7.020.04
+0.57%
FinVolution Group
GRFS7.270.03
+0.41%
Grifols SA
INUV0.45N/A
+0.25%
Inuvo
AJG294.82-0.97
-0.33%
Arthur J Gallagher & Co
TRVI3.76-0.02
-0.53%
Trevi Therapeutics